Centre caps trade margin for cancer drugs at 30% after Supreme Court rap
Cite this
Citations are auto-generated; verify before publishing. The news classification is PolicyDhara's, not the source's.
News coverage — journalism about policy, not a policy document. Useful as timely context; the underlying instrument is linked where known.
Summary
The Central government informed the Supreme Court on Monday that it has capped the trade margins on anti-cancer drugs at 30 percent of the Maximum Retail Price (MRP) [Kishan Chand Jain vs Ethics And Medical Registration Board (EMRB) (Erstwhile Medical Council Of India) And Ors.].A Bench of Justices Vikram Nath and Sandeep Mehta however flagged the exorbitant profit margins on everyday medical items and asked why the Centre’s new price-margin cap has been confined only to anti-cancer drugsThe hea